“Recursion has spent the last decade generating and aggregating one of the largest biological and chemical datasets in the world, purpose-built for training new AI models.

Recursion is eliminating approximately 20% of its workforce, in a restructuring that reflects challenges seen across the biopharma industry.

The Utah-based pharmaceutical company has trained a large language model to enable scientists to tap into dozens of machine learning models at once, saving them time during drug development.

--The business combination of two AI-powered drug discovery and development companies, Recursion and Exscientia has been completed, with Exscientia becoming a wholly owned subsidiary of Recursion ...

Recursion is (in many, but not all) languages slightly slower, and it does have some dangers (smashing the stack), but used properly it's a completely legitimate, valuable tool for production code.

Recursion Pharmaceuticals is laying off a fifth of its workforce in connect with a previously announced streamlining of the AI biotech’s pipeline.